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 Abstract 
Objectives: Borderline ovarian tumors have favorable survival rates, however, prognostic factors are still discussed. 
The aim was to investigate the outcome for women treated conservatively with respect to different tumor-dependent 
and tumor-independent prognostic factors.
Material and methods: 194 women treated surgically between years 1978 and 2007. Influence of conservative 
or radical surgical treatment on survival was evaluated. 
Results: The overall 5-year survival rate was 93.1% and 96.8% respectively for radical and conservative treatment. 
The mean time of survival was longer in women treated conservatively (p = 0.03), but this was an outcome of 
their younger age; when age was eliminated as a determining factor, the type of treatment had not influenced 
the length of postoperative survival (p=0.57). Conservative treatment was chosen more frequently for younger 
women. Factors that are detrimental to survival are age, postmenopausal detection of borderline ovarian tumors, an 
advanced stage of progression, a bilateral localization of tumors, the occurrence of invasive peritoneal implants and 
a serous rather than a mucinous histological type of borderline ovarian tumor, more frequently occurred in women 
treated radically. Borderline ovarian tumors recurred in 16.7% of women after conservative treatment and in 3.5% of 
women after radical treatment. Of women with preserved fertility 25.7% became pregnant at least once and 21.2% 
of the group as a whole delivered children at term; none of the pregnancies were fertility-assisted. 
Conclusions: Conservative treatment does not have a deleterious effect on the prognosis of women provided that 
unfavorable prognostic factors are identified.
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Abbreviations: 
Borderline ovarian tumors (BOTs)
Introduction
Borderline	 ovarian	 tumors	 (BOTs),	 classified	 as	 a	 distinct	
group	of	ovarian	tumors	of	epithelial	origin,	have	a	good	prog-
nosis,	with	a	five-year	survival	rate	that	stands	at	90-98%,	while	
for	recurrence	the	rate	is	7-10%	[1-4].	The	percentage	of	serous	
tumors	which	are	actually	borderline,	given	as	15-20%,	itself	ap-
pears	 to	have	been		underestimated	[5].	BOTs	affect	a	younger	
group	of	women,	often	of	reproductive	age	[1,	2,	6],	and	are	more	
likely	to	be	at	an	early	stage	(approximately	50-85	%	represent	
stage	I	of	the	disease	[4,	7,	8]).	
All	 these	 factors	 weigh	 in	 favor	 of	 conservative	 surgical	
techniques	 that	 avoid	 “overtreatment”	 of	 the	 patient.	 The	 pre-
vailing	procedures	 for	ovarian	cancer	 such	as	peritoneal	wash-
ing,	hysterectomy	with	bilateral	salpingo-oophorectomy,	omen-
tectomy	 and	multiple	 peritoneal	 biopsies	 are	 then	 reserved	 for	
postmenopausal	 women	 or	 premenopausal	 women	 who	 have	
completed	their	families	or	do	not	wish	to	preserve	fertility	[9],	
whereas	less	radical	fertility-sparing	surgery,	including	cystecto-
my,	partial	ovariectomy	or	unilateral	salpingo-oophorectomy	[9,	
10]	is	used	to	treat	young	women	who	still	attach	importance	to	
their	child-bearing	potential	and	in	whom	the	disease	is	at	stage	
I.	However,	while	this	may	apply	at	an	early	stage	of	the	disease,	
the	question	then	arises	as	to	whether	proceeding	conservatively	
with	advanced	BOTs	is	safe.	When	the	neoplasm	has	advanced	to	
a	more	advanced	stage	the	prognosis	is	less	favorable	and	the	risk	
of	progression	or	of	recurrence	is	higher.
Objectives
The	aim	of	the	research	has	been	to	investigate	the	outcome	
for	women	treated	conservatively	with	respect	to	different	tumor-
dependent	and	tumor-independent	prognostic	factors.	
Material and methods
The	 research	 was	 carried	 out	 among	 194	 women	 treated	
surgically	at	the	Clinic	of	Gynecology	at	the	Gdańsk	University	
Hospital	between	1978	and	2007.	Each	patient	was	assigned	to	
either	radical	or	conservative	surgical	treatment	on	the	basis	of	
her	age	and	desire	 to	preserve	 fertility,	 together	with	 the	 result	
of	 an	 intraoperative	 cryosection.	 In	five	 cases	 the	 qualification	
criterion	was	that	the	patient	withheld	consent	for	radical	treat-
ment	 until	 the	final	 result	 of	 the	 pathological	 examination	 had	
been	obtained.	An	intraoperative	examination	in	the	Department	
of	Pathology	at	the	University	Hospital	was	performed	on	all	but	
37	of	 the	women	(the	 reasons	 for	not	carrying	out	 this	 test	are	
explained	below	in	the	results).	
As	a	result,	66	women	(34%)	were	regarded	as	eligible	for	
conservative	treatment.	This	consisted	of	unilateral	cystectomy	in	
14	women	(7.2%),	unilateral	adnexectomy	in	27	women	(13.9%),	
unilateral	adnexectomy	with	cystectomy	of	the	opposite	ovary	in	
two	women	(1.0%)	and	unilateral	adnexectomy	with	a	partial	re-
section	of	the	opposite	ovary	in	23	women	(11.9%).	The	remain-
ing	128	women	 received	 radical	 treatment	as	 follows:	bilateral	
adnexectomy	in	six	women	(3.1%),	total	abdominal	hysterecto-
my	with	bilateral	salpinoophorectomy	in	76	women	(39.2%)	and	
total	abdominal	hysterectomy	with	bilateral	salpinoophorectomy,	
omentecomy	and	appendectomy	in	46	women	(23.7%).	Adjuvant	
chemotherapy	was	administered	to	13	women.	
The	primary	treatment	was	completed	by	close	gynecological	
 Streszczenie        
Cel: Guzy o granicznej złośliwości charakteryzują się korzystnymi współczynnikami całkowitego przeżycia chorych, 
chociaż wciąż dyskutowane jest znaczenie czynników prognostycznych. Celem pracy była analiza porównawcza 
wyników leczenia chorych leczonych oszczędzająco w odniesieniu do różnych czynników rokowniczych zależnych 
i niezależnych od nowotworu. 
Materiał i metody: Przeanalizowano przebieg choroby u 194. kobiet leczonych operacyjnie w latach 1978-2007. 
Oceniono wpływ leczenia operacyjnego oszczędzającego względem radykalnego. 
Wyniki: Całkowite pięcioletnie przeżycie wynosiło 93,1% i 96,8% odpowiednio dla radykalnego i zachowawczego 
leczenia. Mediana czasu przeżycia była dłuższa u kobiet leczonych zachowawczo (p = 0,03), ale było to związane 
z ich młodszym wiekiem. Gdy wyeliminowano czynnik wieku jako czynnik determinujący, rodzaj leczenia nie wpływał 
na czas przeżycia chorych (p = 0.57). Leczenie zachowawcze częściej wybierano u młodszych kobiet. Czynniki 
pogarszające przeżycie to wiek chorych, wykrycie guzów o granicznej złośliwości w wieku pomenopauzalnym, 
zaawansowanie choroby, obustronne występowanie guzów, obecność inwazyjnych wszczepów, typ surowiczy 
guza; były one częściej stwierdzane w  grupie leczonej radykalnie. Wznowy guzów o  granicznej złośliwości 
następowały u 16,7% chorych po leczeniu oszczędzającym oraz u 3,5% chorych po leczeniu radykalnym. Wśród 
kobiet z zachowaną płodnością 25,7% zaszło w ciążę przynajmniej raz, a 21.2% urodziło o czasie. Żadna z ciąż nie 
była efektem technik wspomaganego rozrodu. 
Wnioski: Leczenie zachowawcze nie miało niekorzystnego wpływu na rokowanie chorych, przy założeniu że 
negatywne czynniki ryzyka u chorych były wcześniej zidentyfikowane.  
 Słowa kluczowe: nowotwory jajników / chirurgia ginekologiczna / kobiety / 
     / współczynnik przeżycia / 
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follow-up	over	two	years,	during	which	the	women	were	examined	
every	three	months,	followed	by	systematic	six-monthly	check-
ups	over	the	next	three	years	and	finally	annual	check-ups	in	the	
Outpatient	Clinic	of	out	Department.	The	concluding	evaluation	
of	the	postoperative	course	and	of	the	overall	survival	rate	was	
made	in	September	2013.	
The	study	was	submitted	to	the	university	ethical	committee	
and	deemed	to	be	within	the	confines	of	Polish	law	for	such	stud-
ies	and	exempt	from	formal	approval.
The	groups	that	had	been	designated	according	to	the	type	of	
treatment	they	had	received	were	compared	statistically	with	re-
spect	to	metrical	data,	features	of	the	reproductive	period,	patho-
logical	features,	disease	stage	and	overall	survival.	All	the	calcu-
lations	were	performed	by	a	commercial	program	STATISTICA.
PL	by	means	of	the	following:	Pearson’s	chi-squared	test,	Yates’	
chi-squared	 test	 and	 the	 Mann-Whitney	 U	 test.	 Survival	 was	
evaluated	according	to	the	Kaplan-Meier	method	of	analysis	and	
the	differences	were	compared	by	the	log-rank	and	Cox	F	tests.	
In	order	to	determine	the	respective	influence	of	conservative	or	
radical	surgical	treatment	on	survival,	comparisons	were	made	of	
the	following	three	age-related	subgroups:	women	younger	than	
40	 years,	 those	 aged	 between	 40	 and	 45	 years	 and	 those	 aged	
between	45	and	50.	The	significance	of	the	statistical	differences	
was	taken	as	p	<	0.05.
Results
The	patient	characteristics	are	set	out	in	Table	I.	The	women	
who	received	conservative	treatment	were	younger	and,	as	they	
were	less	likely	to	have	reached	the	menopause,	their	mean	parity	
was	lower.	The	differences	were	statistically	significant.	Of	the	
women	treated	conservatively	seven	women	had	been	diagnosed	
and	treated	conservatively	for	BOT	during	the	course	of	a	preg-
nancy.	
The	histological	features	of	the	BOTs	are	presented	in	Table	
II.	The	serous	histological	type	was	the	most	frequent,	although	
in	women	treated	conservatively	the	majority	of	BOTs	were	of	
the	mucinous	type	(p=0.01).	In	the	fertility-sparing	group	BOTs	
were	more	frequently	diagnosed	at	earlier	stages	of	progression	
(p=0.01)	and	were	usually	unilateral	(p	=	0.004)	with	the	outer	
layer	having	a	smooth	surface	(p=0.01)	with	respect	to	compar-
ison	 of	 the	 surface	 only).	 Peritoneal	 implants	were	 discovered	
only	 in	 one	 patient	 with	 preserved	 fertility,	 compared	 to	 nine	
women	in	the	group	that	had	undergone	radical	surgery	(p=0.02).	
In	women	with	peritoneal	implants	the	prevalence	of	recur-
rence	was	high	(six	out	of	10	women),	and	in	four	of	these	(two	
with	invasive	and	two	with	non-invasive	implants)	the	course	of	
the	disease	ended	in	death	between	5	months	and	3½	years	from	
the	initial	diagnosis.	Radical	measures	were	taken	where	a	return	
of	peritoneal	implants	was	seen	in	women	that	had	been	treated	
conservatively.	
The	intraoperative	histopathological	examination	was	omit-
ted	in	35	women	(18.2%)	as	an	ultrasonographic	view	of	the	tu-
mor	gave	no	cause	for	concern	and	either	Ca-125	levels	were	nor-
mal	(31	women)	or	it	was	not	possible	to	perform	the	test	for	this	
owing	to	systemic	problems	(four	cases).	In	the	women	in	whom	
the	examination	was	performed	promptly,	a	BOT	was	identified	
in	78.5%	cases,	a	benign	tumor	of	the	ovary	in	15.9%	cases,	and	
ovarian	cancer	in	5.6%	cases.	In	this	last	category	only	one	pa-
tient	withheld	consent	to	radical	surgery	during	the	preoperative	
evaluation	before	a	final	pathological	assessment	had	been	made.	
There	was	a	 recurrence	of	BOT	in	8.3%	of	women	and	at	
a	higher	prevalence	in	women	treated	conservatively	(16.7%	vs.	
3.5%,	p=0.002).	The	relapse	after	fertility-sparing	surgery	most	
frequently	involved	the	remaining	ovarian	tissue,	while	after	rad-
ical	surgery	it	occurred	in	the	region	of	the	small	pelvis.	In	gen-
eral	the	recurrence	of	BOT	did	not	influence	the	overall	survival	
rates.	In	three	of	the	women	treated	for	BOT	a	transition	of	the	
tumor	to	ovarian	cancer	was	observed.	In	two	cases	this	followed	
radical	treatment,	while	in	one	case	it	was	found	after	unilateral	
adnexectomy	with	contralateral	cystectomy.
The	overall	5-year	survival	 rate	was	93.1%	and	96.8%	re-
spectively	for	radical	and	conservative	treatment.	The	mean	time	
of	 survival	 was	 longer	 in	 women	 treated	 conservatively	 than	
in	 those	 treated	 radically	 (16.5±9.5	 years	 vs.	 12.5±7.7	 years;	
p=0.03).	However,	calculations	revealed	that	overall	survival	de-
creased	independently	with	age.	Therefore,	if	statistical	analysis	
is	made	taking	into	account	 the	influence	of	age	on	survival,	 it	
would	appear	that	there	is	no	difference	in	the	overall	survival-
rate	between	women	treated	radically	and	those	treated	conserva-
tively	(p=0.57).	Further	analysis	revealed	that	the	prognostic	fac-
tors	in	BOT	were	the	stage	of	the	disease	(p=0.0001)	and	whether	
the	 tumor	was	 unilateral	 or	 bilateral	 (p=0.001).	All	 the	 factors	
that	could	possibly	influence	survival	are	listed	in	Table	III.	
After	 analysis	of	 the	 effect	on	 survival	of	 radical	 excision	
of	ovarian	tissue,	it	turned	out	that	there	were	no	differences	in	
survival	between	women	in	whom	the	ovary	was	removed	with	
the	BOT	and	those	in	whom	only	the	tumor	was	enucleated	with	
preservation	of	the	ovarian	tissue	(p=0.2).
Of	 66	women	with	 preserved	 fertility	 17	 (25.7%)	 became	
pregnant	 at	 least	 once	 and	14	of	 these	 (21.2%	of	 the	group	 as	
a	whole)	delivered	of	a	total	of	18	children	at	term.	None	of	the	
pregnancies	were	fertility-assisted.	
Discussion
Our	research	revealed	that	where	BOTs	are	concerned	con-
servative	treatment	does	not	have	a	deleterious	effect	on	the	prog-
nosis	of	women.	 Indeed	 these	women	survived	 longer,	but	 this	
was	an	outcome	of	their	younger	age	at	the	time	of	the	surgical	
procedure.	Nevertheless,	when	age	was	eliminated	as	a	determin-
ing	factor,	it	was	shown	that	the	type	of	treatment	had	not	influ-
enced	the	length	of	postoperative	survival.	
Evaluation	 of	 the	 factors	 affecting	 the	 overall	 survival	 of	
women	with	BOT	is	difficult	[11]	because	of	the	very	high	sur-
vival	rates	for	this	tumor	(99%	at	stage	I	in	our	study	and	in	the	
literature	 [12]).	Moreover,	 recurrence	 is	 relatively	 rare;	 in	 our	
material	BOTs	 recurred	 in	16.7%	of	women	after	 conservative	
treatment	 and	 in	 3.5%	 of	 women	 after	 radical	 treatment.	 The	
frequency	of	 relapses	 as	 presented	 in	papers	 on	BOT	and	 sys-
tematically	reviewed	by	Darai	et	al.	is	similar	[12],	although	the	
overall	relapse	rate	was	up	to	25%	after	conservative	and	up	to	
5%	after	radical	treatment.	The	increased	incidence	of	recurrence	
after	conservative	treatment	must	be	associated	with	the	fact	that	
these	arise	in	the	spared	ovarian	tissue.	However,	recurrence	does	
not	influence	the	survival	of	women,	as	borne	out	by	our	results.	
In	 the	 literature	 there	 is	 a	 single	 piece	 of	 randomized	 re-
search	on	BOT	by	Palomba	et	al.	[13,	14]	comparing	conserva-
tive	 to	 radical	 treatment,	while	 all	 other	 studies,	 including	 our	
own,	are	retrospective	[4,	15-17].	
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The	worse	 survival	 rate	of	women	after	 radical	 surgery	 in	
our	studies	was	a	consequence	of	the	characteristics	of	this	group,	
in	whom	 unfavorable	 prognostic	 factors	were	more	 frequently	
present.	 It	 has	 been	 found	 independently	 that	 the	 factors	 that	
are	detrimental	to	survival	are	age,	postmenopausal	detection	of	
BOTs,	an	advanced	stage	of	progression,	a	bilateral	localization	
of	 tumors,	 the	 occurrence	 of	 invasive	 peritoneal	 implants	 and	
a	 serous	 rather	 than	 a	 mucinous	 histological	 type	 of	 BOT.	
The	 neoplasm	 stage	 is,	 according	 to	 the	 FIGO	 classification,	
considered	the	strongest	and	most	objective	prognostic	factor	for	
Table  I .  Characteristics of women treated for borderline ovarian tumors with a distinction to the type of surgical treatment.  
Feature 
[mean ± SD (min – max)] all conservative radical p-value
Age at surgery 48.2 ± 16.0
16 – 85
33 ± 12.2
16 – 72
56 ± 11.5
28 – 85 < 0.0001
Number of deliveries 1.5 ± 1.5
0 – 8
0.7 ± 1.0
0 – 5
1.9 ± 1.6
0 – 8 < 0.0001
Number of miscarriages 0.4 ± 1.0
0 – 9
0.2 ± 0.8
0 – 5
0.5 ± 1.1
0 – 9 0.03
Reproductive status    
          
-	 premenopausal 
-	 pregnancy
-	 postmenopausal
n % n % n %
< 0.0001100
7
74
55.2
3.9
40.9
50 
7 
8 
76.9
10.8
12.3
50 
0 
66 
43.1
0.0
56.9
Table  I I .  Tumor-dependent features in women treated conservatively and radically for borderline ovarian tumors.
Feature
all conservative radical
p-value
n % n % n %
Histological type
-	 serous
-	 mucinous
-	 endometroid
-	 mesothelial
-	 Brenner’s tumor
91 
68 
8 
6
17
47.9
35.8
4.2
3.2
8.9
25 
31
2
3
5
37.9
47.0
3.0
4.5
7.6
66
37
6
3
12
53.2
29.8
4.8
2.4
9.7
0.01
FIGO stage
-	 Ia
-	 Ib
-	 Ic
-	 IIa
-	 IIc
-	 IIIc
143 
19 
15
4
1
12 
73.7
9.8
7.7
2.1
0.5
6.2
60
4
1
0
0
1
90.9
6.1
1.5
0.0
0.0
1.5
83
15
14
4
1
11
64.8
11.7
10.9
3.1
0.8
8.6
0.01
Tumor site - unilateral
                 - bilateral
164 
28
85.4
14.6
63
3
95.5
4.5
101
25
80.2
19.8 0.004
Tumor surface
-	 smooth
-	 papillar
-	 rupture of the cyst
137
34
17
72.9
18.1
9.0
54
6
5
83.1
9.2
7.7
83
28
12
67.5
22.8
9.8
0.08
Peritoneal implants
-	 noninvasive
-	 invasive
-	 not defined
174
6 
3 
95.1
3.3
1.6
65
0
0
100.0
0.0
0.0
109
6
3
92.4
5.1
2.5
0.02
Intraoperative frozen section 
-	 BOT,
-	 other benign tumor,
-	 ovarian cancer,
-	 not performed.
128
22
7
35
66.7
11.5
3.6
18.2
44
5
1
16
66.7
7.6
1.5
24.2
84
17
6
19
66.7
13.5
4.8
15.1
0.3
Frequency of staging procedure 62 32.1 13 19.7 49 38.6 0.008
Adjuvant treatment
-	 none,
-	 chemotherapy,
-	 radiotherapy.
172
13
2 
92.0
7.0
1.1
66
0
0
100.0
0.0
0.0
106
13
2
87.6
10.7
1.7
0.003
Frequency of Second Look Operation 8 4.3 3 4.5 5 4.2 0.9
Frequency of recurrence 15 8.3 11 16.7 4 3.5 0.002
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BOTs,	followed	by	histological	type	and	patient	age	at	diagnosis	
[11,	18,	19].
The	 profiles	 of	 the	women	 designated	 for	 conservative	 or	
radical	treatment	are	dissimilar.	Conservative	treatment	was	cho-
sen	more	frequently	for	younger	women	whose	fertility	was,	in	
the	majority	of	cases,	at	its	greatest	and,	in	view	of	the	fact	that	
more	than	half	were	under	the	age	of	40	and	that	half	were	nul-
liparous,	of	considerable	importance	to	the	women.	The	profile	of	
the	women	corresponds	to	the	features	of	BOTs,	which	are	most	
prevalent	 in	 relatively	 young	women	during	 their	 reproductive	
years	[20].	Women	aged	under	40	years	in	our	study	constituted	
31%	of	 the	group	analyzed.	This	corresponds	 to	 the	 results	 re-
ported	by	Sherman	et	al.	[21]	and	Skirnisdottir	et	al.	[22],	who	
showed	 that	 the	 incidence	 of	 BOTs	 in	 women	 aged	 under	 40	
years	 is	 29%	and	34%	 respectively.	As	 a	 consequence	of	 their	
youth,	the	majority	of	women	treated	for	BOT	still	are	planning	
to	have	a	family.	In	our	study	more	than	half	the	women	treated	
conservatively	were	nulliparous.	In	our	study	approximately	25%	
of	 the	women	 conceived	 at	 least	 once	postoperatively,	 and	 the	
rate	of	births	at	term	reached	about	12%.	Moreover,	a	high	stag-
ing	of	the	BOT	observed	in	one	patient	was	not	an	obstacle	for	
having	a	term	birth,	nor	did	it	affect	the	patient’s	survival.	
	Fertility	outcomes	for	women	treated	for	BOT	with	conser-
vative	procedures	have	been	evaluated	and	published	in	a	series	
of	at	least	55	studies.	The	results	of	these	studies	show	that	the	
proportion	of	women	who	achieved	a	pregnancy	after	 fertility-
sparing	surgery	falls	within	the	range	of	7–45%	[12].	It	should,	
however,	be	noted	that	a	pregnancy	rate	of	40–88%	is	given,	con-
siderably	higher	than	in	our	studies,	but	this	percentage	represents	
the	percentage	of	women	actively	trying	to	conceive.	Following	
Darai	et	al.	[12],	the	pooled	estimate	for	spontaneous	pregnancies	
after	conservative	treatment	is	54%,	which	is	significantly	lower	
if	compared	to	the	general	population.	
There	may	be	several	 reasons	 for	 this.	Firstly,	 the	surgical	
procedures	may	reduce	the	ovarian	reserve,	as	shown	by	Palom-
ba	et	al	in	the	only	randomized	studies	on	BOTs	[13,	14].	They	
showed	that	the	pregnancy	rate	was	higher	following	cystectomy	
than	after	adnexectomy	and	that	the	prevalence	of	recurrence	was	
similar	 in	both	groups.	After	 cystectomy,	however,	 the	 time	of	
relapse	formation	was	shorter	and	its	occurrence	more	frequently	
resulted	in	radical	treatment	[14].	Another	reason	for	the	reduced	
percentage	of	spontaneous	pregnancies	after	treatment	for	BOT	
is	 the	 age	 of	women	 at	 the	 time	 they	 conceived.	 Fauvet	 et	 al.	
[23]	and	Kanat-Pektas	et	al.	[24]	have	shown	that	an	age	of	40	
marks	 the	 boundary	 beyond	 which	 the	 chances	 of	 conception	
decline	 rapidly.	 It	 should	 be	 borne	 in	mind,	 however,	 that	 this	
team	of	writers	did	not	measure	two	parameters	known	to	influ-
ence	 fertility,	namely	 the	number	of	antral	 follicles	and	Serum	
anti-Müllerian	hormone	concentration.	The	third	factor	influenc-
ing	the	fertility	rates	is	the	histological	type	of	BOT.	As	shown	
by	Kanat-Pektas	et	 al.	 [24],	 in	women	with	 the	mucinous	 type	
the	number	of	pregnancies	achieved	was	very	high	compared	to	
women	with	serous	BOTs.	This	may	be	a	consequence	of	the	fact	
that	serous	BOTs	are	more	likely	to	occur	bilaterally	with	a	peri-
toneal	spread,	usually	in	women	that	have	a	history	of	infertility	
treatment	[25,	26].
Attention	 is	 increasingly	 being	 drawn	 to	 the	 presence	 of	
peritoneal	implants	as	a	prognostic	factor,	and	especially	to	the	
significance	of	their	type	[11,	12].	Although	our	study	gave	little	
opportunity	 to	 evaluate	 the	 safety	 of	 conservative	 treatment	 in	
women	with	peritoneal	 implants	 (as	only	one	patient	was	con-
cerned),	two	major	studies	by	Zanetta	et	al.	[27]	and	Uzan	et	al.	
[28]	 have	 revealed	 that	 conservative	 treatment	 may	 be	 safely	
used	 in	women	with	non-invasive	 implants	provided	 that	 these	
are	totally	excised.	In	view	of	the	fact	that	there	is	a	paucity	of	
literature	on	the	conservative	treatment	of	women	with	invasive	
implants,	 the	safety	of	 this	method	must	 still	be	open	 to	doubt	
[27-30].	
Tailored	 surgery	 in	 women	 with	 ovarian	 tumors	 is	 based	
on	correct	decisions	regarding	eligibility	for	a	particular	type	of	
treatment	on	the	basis	of	the	ultrasonographic	view	of	the	ovarian	
lesion	and	the	level	of	Ca-125	marker,	together	with	the	patient’s	
age	 at	 diagnosis,	 reproductive	 plans	 and	 consent	 to	 treatment.	
Intraoperative	frozen	section	diagnosis	of	BOT	is,	however,	de-
cisive.	In	our	study	this	test	revealed	borderline	tumor	histology	
in	only	two	thirds	of	cases.	Approximately	a	sixth	of	women	did	
not	undergo	this	test	initially,	mainly	owing	to	an	absence	of	pre-
operative	clinical	indications.	However,	in	approximately	a	fifth	
of	 women	 the	 diagnosis	 had	 been	 incorrect.	 In	 5.6%	 ovarian	
cancer	had	been	diagnosed	and	in	15.0%	benign	tumors,	result-
ing	 in	overtreatment	or	undertreatment	respectively.	Studies	by	
Gultekin	et	al.	[31],	Tempfer	et	al.	[32]	and	Liu	et	al.	[33]	have	
revealed	 that	 the	 underdiagnosis	 rate	 for	BOTs	 is	 29.3%,	 28%	
and	 25.7%	 respectively.	 The	 retrospective	 multicenter	 pooled	
analysis	reported	by	Tempfer	et	al.	[32]	showed	that	in	280	wom-
en	with	a	final	diagnosis	of	BOT	as	many	as	25%	women	had	
been	diagnosed	for	benign	lesions	and	3.6%	for	ovarian	cancer	
in	the	intraoperative	cryosection.	On	the	other	hand,	of	women	
who	received	a	final	diagnosis	of	ovarian	cancer	an	intraoperative	
diagnosis	of	BOT	had	been	given	for	11.4%.	The	intraoperative	
evaluation	of	BOT	is	known	to	be	difficult,	especially	when	the	
tumor	is	large,	as	a	limited	invasive	component	of	such	a	lesion	
may	be	easily	missed	[11].	
Table  I I I .  The influence of chosen tumor-dependent and tumor-independent 
factors on the overall survival rates in women treated for borderline ovarian tumors. 
 
Features p-value
- age at surgery 0.01
- age at menarche 0.9
- premenopausal vs. postmenopausal period 0.01
- number of deliveries before surgery 0.01
- having a pregnancy after surgery 0.06
- histological type: serous vs. mucinous 0.01
- stage of the disease 0.001
- unilateral vs. bilateral site of BOT 0.001
- cystectomy vs. adnexectomy 0.2
- performing the staging procedure 0.8
- rupture of the cyst 0.05
- recurrence 0.06
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Conclusions
The	results	presented	support	the	theses	that	tailored	surgi-
cal	treatment	guarantees	the	best	outcome	and	that	conservative	
treatment	is	not	a	choice	between	a	good	prognosis	over	procre-
ative	success	and	a	reduced	risk	of	later	complications.	
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